CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Accounts Payable
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Accounts Payable of $714.38 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2014-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2014-06-30 was $1.11M, a 75.67% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2014-03-31 was -$398.99K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2013-06-30 was $4.58M.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2013-03-31 was -$3.17M, a 216.36% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2011 was -$1.93M, a 315.45% decline from fiscal 2010.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2010 was $895.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2014-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $714.38K 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | -$398.99K 10-Q · filed 2014-05-15 | |||
| 2013-06-30 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.40M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$3.17M 10-Q · filed 2014-05-15 | |||
| 2012-03-31 | $2.73M 10-Q · filed 2012-05-14 | $2.73M derived: sum of 2 quarters · filed 2012-05-14 | $3.00M derived: sum of 3 quarters · filed 2012-05-14 | $2.06M derived: sum of 4 quarters · filed 2012-05-14 |
| 2011-12-31 | $5.56K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $276.50K derived: sum of 2 quarters · filed 2012-03-14 | -$666.84K derived: sum of 3 quarters · filed 2012-03-14 | -$1.93M 10-K · filed 2012-03-14 |
| 2011-09-30 | $270.94K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | -$672.40K derived: sum of 2 quarters · filed 2012-03-06 | -$1.93M 10-Q/A · filed 2012-03-06 | -$1.32M derived: sum of 4 quarters · filed 2012-05-14 |
| 2011-06-30 | -$943.33K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-09-06 | -$2.20M 10-Q/A · filed 2011-09-06 | -$1.59M derived: sum of 3 quarters · filed 2012-05-14 | -$3.71M derived: sum of 4 quarters · filed 2012-05-14 |
| 2011-03-31 | -$1.26M 10-Q · filed 2012-05-14 | -$643.70K derived: sum of 2 quarters · filed 2012-05-14 | -$2.77M derived: sum of 3 quarters · filed 2012-05-14 | |
| 2010-12-31 | $617.73K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$1.51M derived: sum of 2 quarters · filed 2012-03-14 | $895.00K 10-K · filed 2012-03-14 | |
| 2010-09-30 | -$2.13M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $277.27K 10-Q/A · filed 2012-03-06 | ||
| 2010-06-30 | $2.40M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |